ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

REGN Regeneron Pharmaceuticals Inc

883.20
-7.48 (-0.84%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Regeneron Pharmaceuticals Inc REGN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-7.48 -0.84% 883.20 09:00:00
始値 安値 高値 終値 前日終値
881.72 875.225 887.4794 883.20 890.68
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2520:00GLOBERegeneron and Mammoth Biosciences Collaborate to Pursue..
2024/4/2423:05GLOBERegeneron to Showcase Progress in Advancing Novel..
2024/4/2306:54GLOBERegeneron to Highlight Advances in Genetic Medicine Research..
2024/4/1620:18IHMARKETNEWSEricsson Soars with 66% Net Profit Growth; Live Nation Under..
2024/4/1120:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
2024/4/0805:00GLOBELinvoseltamab Pivotal Data Presented at AACR Reinforce High..
2024/4/0205:05GLOBERegeneron to Report First Quarter 2024 Financial and..
2024/3/2520:00GLOBERegeneron Provides Update on Biologics License Application..
2024/3/1312:55PRNUSHigh School Seniors Win $1.8 Million at Regeneron Science..
2024/3/1310:30GLOBEHigh School Seniors Win $1.8 Million at Regeneron Science..
2024/3/1120:00GLOBEPraluent® (alirocumab) Injection Receives FDA Approval to..
2024/3/0821:00GLOBEEYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet..
2024/3/0606:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0206:14EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2906:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2906:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2906:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:34EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2706:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:07EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2706:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2705:25EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2406:04EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2315:00GLOBEDupixent® (dupilumab) sBLA Accepted for FDA Priority Review..
2024/2/2307:10EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2306:06EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2121:00GLOBELinvoseltamab BLA for Treatment of Relapsed/Refractory..
2024/2/2106:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1614:59GLOBEJapan First in the World to Approve Dupixent® (dupilumab)..
2024/2/1507:08EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1008:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1006:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:04EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1002:22EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0906:56EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0906:26EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0906:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0906:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/0807:59EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0807:07EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0806:35EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0706:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0706:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0706:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0706:05GLOBERegeneron Announces Investor Conference Presentations

最近閲覧した銘柄

Delayed Upgrade Clock